{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T13:13:34Z","timestamp":1788614014575,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020205","name":"Jiangxi Province Health Commission","doi-asserted-by":"publisher","award":["2026Y0048"],"award-info":[{"award-number":["2026Y0048"]}],"id":[{"id":"10.13039\/501100020205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.seminoncol.2026.152525","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:12:51Z","timestamp":1785424371000},"page":"152525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A bibliometric analysis of research evolution on peritoneal metastasis in colorectal cancer (2000\u20132026): advances in molecular mechanisms and therapeutic strategies"],"prefix":"10.1016","volume":"53","author":[{"given":"Shirui","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangteng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.seminoncol.2026.152525_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152525_bib0002","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.seminoncol.2026.152525_bib0003","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1067\/j.cpsurg.2018.08.004","article-title":"Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?","volume":"55","author":"Stewart","year":"2018","journal-title":"Curr Probl Surg"},{"issue":"15","key":"10.1016\/j.seminoncol.2026.152525_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155255","article-title":"Distant metastasis in colorectal cancer patients-do we have new predicting clinicopathological and molecular biomarkers? A comprehensive review","volume":"21","author":"Filip","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.seminoncol.2026.152525_bib0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11864-018-0563-8","article-title":"Metastatic colorectal cancer to the peritoneum: current treatment options","volume":"19","author":"Vassos","year":"2018","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152525_bib0006","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000454687","article-title":"Pattern and dynamics of distant metastases in metastatic colorectal cancer","volume":"33","author":"Holch","year":"2017","journal-title":"Visc Med"},{"issue":"23","key":"10.1016\/j.seminoncol.2026.152525_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15235641","article-title":"Peritoneal metastasis: a dilemma and challenge in the treatment of metastatic colorectal cancer","volume":"15","author":"Xia","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.seminoncol.2026.152525_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24097922","article-title":"Theranostics nanomedicine applications for colorectal cancer and metastasis: recent advances","volume":"24","author":"Kasi","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.seminoncol.2026.152525_bib0009","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10555-023-10158-3","article-title":"Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments","volume":"43","author":"Abedizadeh","year":"2024","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.seminoncol.2026.152525_bib0010","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3389\/fimmu.2020.01624","article-title":"Colorectal cancer immunotherapy: options and strategies","volume":"11","author":"Johdi","year":"2020","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.seminoncol.2026.152525_bib0011","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"Jama"},{"issue":"3","key":"10.1016\/j.seminoncol.2026.152525_bib0012","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s43018-025-00910-9","article-title":"Microbiome dysbiosis, neutrophil recruitment and mesenchymal transition of mesothelial cells promotes peritoneal metastasis of colorectal cancer","volume":"6","author":"Li","year":"2025","journal-title":"Nat Cancer"},{"key":"10.1016\/j.seminoncol.2026.152525_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1296783","article-title":"Crosstalk between gut microbiota and metastasis in colorectal cancer: implication of neutrophil extracellular traps","volume":"14","author":"Wu","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.seminoncol.2026.152525_bib0014","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/path.4281","article-title":"Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis","volume":"231","author":"Sandoval","year":"2013","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152525_bib0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12029-025-01176-1","article-title":"Trends in colorectal cancer peritoneal metastases research: a comprehensive bibliometric analysis","volume":"56","author":"Zhang","year":"2025","journal-title":"J Gastrointestin Cancer"},{"issue":"5","key":"10.1016\/j.seminoncol.2026.152525_bib0016","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0002-9610(77)90003-4","article-title":"Palliative resections in the treatment of primary colorectal cancer","volume":"133","author":"Takaki","year":"1977","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.seminoncol.2026.152525_bib0017","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-2005-916280","article-title":"Surgical management of carcinomatosis from colorectal cancer","volume":"18","author":"Sugarbaker","year":"2005","journal-title":"Clin Colon Rectal Surg"},{"issue":"3","key":"10.1016\/j.seminoncol.2026.152525_bib0018","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01274232","article-title":"Surgical management of peritoneal carcinosis: diagnosis, prevention and treatment","volume":"373","author":"Sugarbaker","year":"1988","journal-title":"Langenbecks Arch Chir"},{"issue":"10","key":"10.1016\/j.seminoncol.2026.152525_bib0019","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/BF02554625","article-title":"Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment","volume":"30","author":"Sugarbaker","year":"1987","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.seminoncol.2026.152525_bib0020","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/01.sla.0000197702.46394.16","article-title":"Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies","volume":"243","author":"Koppe","year":"2006","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.seminoncol.2026.152525_bib0021","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1007\/s00423-021-02323-5","article-title":"Pelvic exenteration, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: experience and outcomes from an exenterative and peritonectomy unit","volume":"406","author":"Flood","year":"2021","journal-title":"Langenbecks Arch Surg"},{"issue":"6","key":"10.1016\/j.seminoncol.2026.152525_bib0022","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152525_bib0023","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10238-025-01868-9","article-title":"Metastatic organotropism in peritoneal metastasis: paget's hypothesis revisited","volume":"26","author":"Kim","year":"2026","journal-title":"Clin Exp Med"},{"issue":"5","key":"10.1016\/j.seminoncol.2026.152525_bib0024","first-page":"2087","article-title":"Colorectal cancer: seed and soil hypothesis revisited","volume":"34","author":"Seretis","year":"2014","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.seminoncol.2026.152525_bib0025","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrclinonc.2011.44","article-title":"Hellman S: oligometastases revisited","volume":"8","author":"Weichselbaum","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152525_bib0026","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152525_bib0027","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12943-019-0976-4","article-title":"Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis","volume":"18","author":"Wei","year":"2019","journal-title":"Mol Cancer"},{"issue":"5","key":"10.1016\/j.seminoncol.2026.152525_bib0028","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.21037\/apm-20-919","article-title":"The multidisciplinary management of oligometastases from colorectal cancer: a narrative review","volume":"10","author":"Chandy","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.seminoncol.2026.152525_bib0029","doi-asserted-by":"crossref","DOI":"10.1038\/srep29765","article-title":"Patterns of metastasis in colon and rectal cancer","volume":"6","author":"Riihim\u00e4ki","year":"2016","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.seminoncol.2026.152525_bib0030","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1158\/1078-0432.CCR-24-3780","article-title":"Spatial heterogeneity, stromal phenotypes, and therapeutic vulnerabilities in colorectal cancer peritoneal metastasis","volume":"31","author":"Ong","year":"2025","journal-title":"Clin Cancer Res"},{"issue":"Suppl 1","key":"10.1016\/j.seminoncol.2026.152525_bib0031","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.21037\/jgo-20-136","article-title":"Omics analyses in peritoneal metastasis-utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative review","volume":"12","author":"Lund-Andersen","year":"2021","journal-title":"J Gastrointest Oncol"},{"issue":"6 Suppl","key":"10.1016\/j.seminoncol.2026.152525_bib0032","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/1097-0142(19950315)75:6+<1539::AID-CNCR2820751526>3.0.CO;2-L","article-title":"Fucosyltransferase of the peritoneum contributed to the adhesion of cancer cells to the mesothelium","volume":"75","author":"Asao","year":"1995","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.seminoncol.2026.152525_bib0033","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"14","key":"10.1016\/j.seminoncol.2026.152525_bib0034","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/0959-8049(94)00473-I","article-title":"Colorectal cancer and the integrin family of cell adhesion receptors: current status and future directions","volume":"30A","author":"Agrez","year":"1994","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.seminoncol.2026.152525_bib0035","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.3390\/cancers13102505","article-title":"The interaction between reactive peritoneal mesothelial cells and tumor cells via extracellular vesicles facilitates colorectal cancer dissemination","volume":"13","author":"Serrat\u00ec","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"24","key":"10.1016\/j.seminoncol.2026.152525_bib0036","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1158\/1078-0432.CCR-08-0480","article-title":"Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741","volume":"14","author":"Fuchs","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.seminoncol.2026.152525_bib0037","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1054\/bjoc.2001.1936","article-title":"Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors","volume":"85","author":"Shaheen","year":"2001","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.seminoncol.2026.152525_bib0038","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/jso.23189","article-title":"Summary of current therapeutic options for peritoneal metastases from colorectal cancer","volume":"107","author":"Chua","year":"2013","journal-title":"J Surg Oncol"},{"issue":"16","key":"10.1016\/j.seminoncol.2026.152525_bib0039","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1002\/cncr.25116","article-title":"3rd: cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis","volume":"116","author":"Franko","year":"2010","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.seminoncol.2026.152525_bib0040","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.seminoncol.2026.152525_bib0041","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.seminoncol.2026.152525_bib0042","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11123406","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a summary of key clinical trials","volume":"11","author":"Turner","year":"2022","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.seminoncol.2026.152525_bib0043","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1007\/s11605-019-04447-y","article-title":"Oxaliplatin versus Mitomycin C following complete cytoreduction for colorectal peritoneal metastases: a comparative study","volume":"24","author":"Narasimhan","year":"2020","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.seminoncol.2026.152525_bib0044","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.critrevonc.2019.06.014","article-title":"de Hingh I: systematic review of published literature on oxaliplatin and mitomycin C as chemotherapeutic agents for hyperthermic intraperitoneal chemotherapy in patients with peritoneal metastases from colorectal cancer","volume":"142","author":"Wisselink","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"10.1016\/j.seminoncol.2026.152525_bib0045","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1245\/s10434-022-12221-9","article-title":"Peritoneal metastases of colorectal origin treated with complete cytoreduction and hyperthermic intraperitoneal chemotherapy: the efficiency of Mitomycin C","volume":"29","author":"Delhorme","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152525_bib0046","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1245\/s10434-023-14368-5","article-title":"2022 Peritoneal Surface Oncology Group International consensus on HIPEC regimens for Peritoneal malignancies: colorectal cancer","volume":"31","author":"H\u00fcbner","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.seminoncol.2026.152525_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2025.110080","article-title":"The Mitomycin versus Oxaliplatin debate on HIPEC in colorectal cancers - an updated systematic review and meta-analysis","volume":"51","author":"Kazi","year":"2025","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.seminoncol.2026.152525_bib0048","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1245\/s10434-025-17363-0","article-title":"Consensus guideline for the management of colorectal cancer with peritoneal metastases","volume":"33","author":"Schultz","year":"2026","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.seminoncol.2026.152525_bib0049","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152525_bib0050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00384-023-04340-w","article-title":"Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal metastasis of colorectal cancer: long-term follow-up results at a single institution in Korea","volume":"38","author":"Lee","year":"2023","journal-title":"Int J Colorectal Dis"},{"issue":"5","key":"10.1016\/j.seminoncol.2026.152525_bib0051","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00535-015-1122-8","article-title":"Factors affecting recurrence and prognosis after R0 resection for colorectal cancer with peritoneal metastasis","volume":"51","author":"Sato","year":"2016","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152525_bib0052","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1186\/s12967-024-05467-2","article-title":"Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer","volume":"22","author":"Lund-Andersen","year":"2024","journal-title":"J Transl Med"},{"issue":"9","key":"10.1016\/j.seminoncol.2026.152525_bib0053","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1136\/gutjnl-2016-311849","article-title":"RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation","volume":"66","author":"Yan","year":"2017","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152525_bib0054","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ccell.2017.12.004","article-title":"Clinical sequencing defines the genomic landscape of metastatic colorectal cancer","volume":"33","author":"Yaeger","year":"2018","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.seminoncol.2026.152525_bib0055","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1245\/s10434-021-10049-3","article-title":"The landmark series: surgical treatment of colorectal cancer peritoneal metastases","volume":"28","author":"Bijelic","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.seminoncol.2026.152525_bib0056","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jso.21068","article-title":"The intraoperative staging systems in the management of peritoneal surface malignancy","volume":"98","author":"Portilla","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.seminoncol.2026.152525_bib0057","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152525_bib0058","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1038\/s41467-022-32198-z","article-title":"Molecular characterization of colorectal cancer related peritoneal metastatic disease","volume":"13","author":"Lenos","year":"2022","journal-title":"Nature Communications"},{"key":"10.1016\/j.seminoncol.2026.152525_bib0059","doi-asserted-by":"crossref","DOI":"10.1038\/s41388-026-03861-2","article-title":"Transcriptomic profiling identifies immunotherapy-responsive phenotypes in microsatellite-stable metastatic colorectal cancer","author":"Konecny","year":"2026","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.seminoncol.2026.152525_bib0060","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1245\/s10434-025-19057-z","article-title":"Consensus molecular subtypes inform HIPEC agent selection in colorectal cancer peritoneal metastases","volume":"33","author":"Gupta","year":"2026","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.seminoncol.2026.152525_bib0061","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005345","article-title":"Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice","volume":"10","author":"K\u00fc\u00e7\u00fckk\u00f6se","year":"2022","journal-title":"J Immunother Cancer"},{"issue":"6","key":"10.1016\/j.seminoncol.2026.152525_bib0062","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.seminoncol.2026.152525_bib0063","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041125","article-title":"10 Years of pressurized intraperitoneal aerosol chemotherapy (PIPAC): a systematic review and meta-analysis","volume":"15","author":"Di Giorgio","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152525_bib0064","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12957-021-02357-5","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal malignancy: initial experience of the first program in the Baltic countries","volume":"19","author":"Ra\u010dkauskas","year":"2021","journal-title":"World J Surg Oncol"},{"issue":"7_Supplement","key":"10.1016\/j.seminoncol.2026.152525_bib0065","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2026-3958","article-title":"Abstract 3958: spatial transcriptomic profiling of peritoneal metastases identifies multicellular programs in patient tumors undergoing pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"86","author":"Natri","year":"2026","journal-title":"Cancer Research"},{"key":"10.1016\/j.seminoncol.2026.152525_bib0066","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.70420","article-title":"Circulating tumor DNA and precision biomarkers in colorectal cancer: implications for diagnosis, monitoring, and management of advanced disease","author":"Srinivasalu","year":"2026","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.seminoncol.2026.152525_bib0067","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41571-020-0392-0","article-title":"ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper","volume":"17","author":"Dasari","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.seminoncol.2026.152525_bib0068","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.5114\/pjr.2023.125027","article-title":"Diagnosis and treatment of peritoneal carcinomatosis - a comprehensive overview","volume":"88","author":"Szadkowska","year":"2023","journal-title":"Pol J Radiol"},{"key":"10.1016\/j.seminoncol.2026.152525_bib0069","article-title":"A new paradigm in postoperative colorectal cancer surveillance: integrating advanced imaging and multi-omics","volume":"16","author":"Yu","year":"2025","journal-title":"Front Physiol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775426000722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775426000722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T12:46:08Z","timestamp":1788612368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775426000722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0093775426000722"],"URL":"https:\/\/doi.org\/10.1016\/j.seminoncol.2026.152525","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A bibliometric analysis of research evolution on peritoneal metastasis in colorectal cancer (2000\u20132026): advances in molecular mechanisms and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seminoncol.2026.152525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152525"}}